The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
Launched by CASE WESTERN RESERVE UNIVERSITY · Mar 16, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how sounds from the womb can help the brains of preterm infants develop better control over their breathing. Preterm infants often face challenges such as pauses in breathing (called apnea), low oxygen levels (intermittent hypoxemia), and slow heart rates (bradycardia). The researchers want to see if exposing these infants to sounds they heard while in the womb can improve the areas of their brains responsible for breathing control.
To participate in this trial, infants must be born preterm, specifically between 29 and 33 weeks of gestation, and be at least 34 weeks of corrected age. They also need to be off respiratory support that provides more than 1.5 liters of oxygen per minute. Those who are still on high levels of respiratory support or have certain congenital anomalies are not eligible. If your infant qualifies, they will be part of a study that explores the effects of early sound exposure on their development, which could have positive implications for their health and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • preterm infants 29-33 weeks gestational age at birth
- • 34 weeks corrected age
- • off respiratory support \>1.5 lpm
- Exclusion Criteria:
- • on respiratory support \>1.5 lpm
- • congenital anomalies
About Case Western Reserve University
Case Western Reserve University (CWRU) is a leading research institution located in Cleveland, Ohio, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, CWRU integrates expertise from various fields, including medicine, engineering, and social sciences, to address complex health challenges. The university's clinical trial initiatives are designed to foster the development of novel therapies and interventions, ensuring rigorous scientific methodologies and ethical standards are upheld. CWRU is dedicated to translating research findings into tangible benefits for patients and communities, contributing significantly to the advancement of healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Cynthia Bearer, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials